Top Clinical Trials companies in Finland by Return on Assets (ROA)
This ranking features the top 1 Clinical Trials companies in Finland ranked by Return on Assets (ROA), averaging a Return on Assets (ROA) of 14.33%, for February 07, 2025.
Finland
Clinical Trials
Return on Assets (ROA)
# |
Name |
Return on Assets (ROA) |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
14.33%
|
Dec. 31, 2023 | USD 3.15 | 0.25% |
|
Finland |
Frequently Asked Questions
-
Which Clinical Trials company in Finland has the highest Return on Assets (ROA) ?
The Clinical Trials company in Finland with the highest Return on Assets (ROA) is Biohit Oyj (Helsinki Stock Exchange: BIOBV.HE) at 14.33%.
-
Which Clinical Trials company in Finland has the lowest Return on Assets (ROA) ?
The Clinical Trials company in Finland with the lowest Return on Assets (ROA) is Biohit Oyj (Helsinki Stock Exchange: BIOBV.HE) at 14.33%.
-
What are the top 10 Clinical Trials companies in Finland by Return on Assets (ROA) ?
The top 10 Clinical Trials companies in Finland by Return on Assets (ROA) are and Biohit Oyj.
-
What are the bottom 10 Clinical Trials companies in Finland by Return on Assets (ROA) ?
The bottom 10 Clinical Trials companies in Finland by Return on Assets (ROA) are and Biohit Oyj.
